Trial Profile
Dose Escalation Study of Sanaria's Irradiated Sporozoite Vaccine (PFSPZ Vaccine), Followed by a Randomized, Double-Blind, Placebo-Controlled Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of PfSPZ Vaccine in Malaria-Experienced Adults in Burkina Faso.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Oct 2021
Price :
$35
*
At a glance
- Drugs Malaria vaccine live attenuated-Sanaria (Primary) ; Artesunate
- Indications Falciparum malaria
- Focus Adverse reactions
- 10 Jan 2019 Status changed from active, no longer recruiting to completed.
- 20 Jul 2017 Planned End Date changed from 3 Oct 2017 to 20 Apr 2019.
- 20 Jul 2017 Planned primary completion date changed from 1 Apr 2017 to 20 Apr 2019.